Salute e Benessere
Terumo Neuro Launches Aneurysm Treatment Alliance in EMEA to Advance Physician Collaboration and Aneurysm Care
The Aneurysm Treatment Alliance is a new EMEA initiative created to strengthen engagement with physicians, streamline collaboration, and highlight Terumo Neuro's differentiated hemorrhagic portfolio for aneurysm treatment. By providing standardized tools and a collaborative platform, the Alliance supports physicians in advancing patient care across the region.
The Aneurysm Treatment Alliance will feature:
"Our hemorrhagic portfolio leads the way in delivering innovative solutions, grounded in strong clinical outcomes, that empower physicians to confidently treat a wide range of aneurysms," said Sebastien Chabeauti, Vice President and General Manager, EMEA, Terumo Neuro. "The Aneurysm Treatment Alliance brings this commitment to life by providing physicians across EMEA with practical tools and collaborative opportunities to elevate aneurysm treatment. This launch also reflects our laser-focused dedication to physician partnerships, innovation, and improving patient outcomes worldwide."
We're in business to create and deliver innovations that redefine what's possible in neurovascular treatment, meaningfully advancing both physician practice and patient outcomes. Founded in 1997 as MicroVention and acquired by Terumo Corporation in 2006, Terumo Neuro offers more than thirty products for the treatment of cerebral aneurysms, ischemic stroke, carotid artery disease, and neurovascular malformations. Headquartered in
Aliso Viejo, California , Terumo Neuro products are sold in more than seventy countries through a dedicated sales organization as well as strategic distribution partnerships. Manufacturing facilities are in
Aliso Viejo, California , and San José,
Costa Rica . For more information, please visit www.terumoneuro.com .
Terumo (TSE:4543) is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for more than 100 years. Based in Tokyo and operating globally, Terumo employs over 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company began as a Japanese thermometer manufacturer and now offers an extensive portfolio—from vascular intervention and cardio-surgical solutions to blood transfusion, cell therapy technology, and essential clinical products.
Christine McCullough
Head of Global Communications
Terumo Neuro
+ 1 714 206 9800
Christine.mccullough@terumo.com
Logo - https://mma.prnewswire.com/media/2613109/Terumo_Neuro___Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/terumo-neuro-launches-aneurysm-treatment-alliance-in-emea-to-advance-physician-collaboration-and-aneurysm-care-302543964.html